Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)

NCT04484415 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3

Interventions

COMBINATION_PRODUCT: Cevira®
COMBINATION_PRODUCT: Placebo

Sponsor

Asieris MediTech (Hong Kong) Co., Ltd.